Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

High Expression of BCAT1 Affects DNA Damage Response By Inhibiting α-KG-Dependent Histone Demethylase

Jiajia Pan, Jie Jin, Yungui Wang, Shujuan Huang, Wenwen Wei, Shihui Mao, Qing Ling, Chenying Li, Jinghan Wang

Blood (2022) 140 (Supplement 1): 8717–8719.

https://doi.org/10.1182/blood-2022-165155

Published: 2022

Journal Articles

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Xin Huang, Yungui Wang, Huan Xu, Hongyan Tong, Hong-hu Zhu, Jie Jin

Blood (2022) 140 (Supplement 1): 3350–3351.

https://doi.org/10.1182/blood-2022-165738

Published: 2022

Journal Articles

Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia

Huafeng Wang, Jiejing Qian, Chang Yang, Yi Zhang, Yungui Wang, Ting Shi, Yongxian HU, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong-Hu Zhu

Blood (2021) 138 (Supplement 1): 3395.

https://doi.org/10.1182/blood-2021-152836

Published: 2021

Journal Articles

High Expression of BCAT1 promotes Acute Myeloid Leukemia Progression and Sensitize to PARP Inhibitor

Jie Jin, PhD, Jie Jin, PhD, Jiajia Pan, Yungui Wang, PhD, Shujuan Huang, Shihui Mao, Qing Ling, Jinghan Wang, MD PhD, Chenying Li

Blood (2019) 134 (Supplement_1): 5041.

https://doi.org/10.1182/blood-2019-125221

Published: 2019

Journal Articles

Multidimensional Study on the Prognostic Factors of Acute Myeloid Leukemia Patients with FLT3-ITD mutations Based on the Next-Generation Sequencing Platform

Yi Zhang, MDcal Master, Bide Zhao, Yungui Wang, PhD, Dongmei Wang, Hanzhang Pan, Chengcheng Wang, Feng Lou, Shanbo Cao, Jie Jin, MD PhD

Blood (2018) 132 (Supplement 1): 5281.

https://doi.org/10.1182/blood-2018-99-116178

Published: 2018

Journal Articles

Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 857.

https://doi.org/10.1182/blood.V130.Suppl_1.857.857

Published: 2017

Journal Articles

Fto Plays an Oncogenic Role in Acute Myeloid Leukemia As a N 6 -Methyladenosine RNA Demethylase

Blood (2016) 128 (22): 2706.

https://doi.org/10.1182/blood.V128.22.2706.2706

Published: 2016

Journal Articles

TET1 Regulates DNA Replication through Targeting of Minichromosome Maintenance Genes

Blood (2016) 128 (22): 2687.

https://doi.org/10.1182/blood.V128.22.2687.2687

Published: 2016

Journal Articles

Alox5 Functions As Both Tumor Suppressor and Drug Sensitizer in AML

Xi Jiang, PhD, Yungui Wang, PhD, Chao Hu, PhD, Jennifer Strong, Lei Dong, PhD, Rui Su, PhD, Hengyou Weng, PhD, Huilin Huang, PhD, Chenying Li, Jie Jin, MD PhD, Jianjun Chen, PhD

Blood (2016) 128 (22): 2851.

https://doi.org/10.1182/blood.V128.22.2851.2851

Published: 2016

Journal Articles

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Blood (2016) 128 (22): 5058.

https://doi.org/10.1182/blood.V128.22.5058.5058

Published: 2016

Journal Articles

Overexpression and Knockout of Mir-126 Both Promote Leukemogenesis through Targeting Distinct Gene Signaling

Blood (2015) 126 (23): 3667.

https://doi.org/10.1182/blood.V126.23.3667.3667

Published: 2015

Journal Articles

Uncover TET1 Targets in MLL -Rearranged Leukemia

Hengyou Weng, PhD, Huilin Huang, PhD, He Huang, PhD, Okwang Kwon, Ping Chen, Xi Jiang, PhD, Chao Hu, Hao Huang, PhD, Yungui Wang, PhD, Xi Qin, Stephen Arnovitz, Shenglai Li, Jennifer Strong, Rui Su, PhD, Mary Beth Neilly, Zejuan Li, MD PhD, Yingming Zhao, Jianjun Chen, PhD

Blood (2015) 126 (23): 3632.

https://doi.org/10.1182/blood.V126.23.3632.3632

Published: 2015

Journal Articles

Targeted Treatment of FLT3 -Overexpressing Acute Myeloid Leukemia with MiR-150 Nanoparticles Guided By Conjugated FLT3 Ligand Peptides

Blood (2015) 126 (23): 3784.

https://doi.org/10.1182/blood.V126.23.3784.3784

Published: 2015

Journal Articles

Mircrorna-550 Functions As a Critical Tumor Suppressor in Acute Myeloid Leukemia

Chao Hu, Xi Jiang, PhD, Bryan Ulrich, Yungui Wang, PhD, Rui Su, PhD, Hengyou Weng, PhD, Huilin Huang, PhD, Jennifer Strong, Ping Chen, Shenglai Li, Jianjun Chen, PhD, Jie Jin, MD PhD

Blood (2015) 126 (23): 1240.

https://doi.org/10.1182/blood.V126.23.1240.1240

Published: 2015

Journal Articles

Overexpression and knockout of miR-126 both promote leukemogenesis

Blood (2015) 126 (17): 2005–2015.

https://doi.org/10.1182/blood-2015-04-639062

Published: 2015

Includes: Supplemental data

Journal Articles

Identification of TET1⊣miR-22⊣CREB-MYC Signaling Reveals Potent Tumor-Suppressor Role of Mir-22 in Acute Myeloid Leukemia

Blood (2014) 124 (21): 886.

https://doi.org/10.1182/blood.V124.21.886.886

Published: 2014

Journal Articles

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL -Rearranged Leukemia

Hao Huang, PhD, Xi Jiang, PhD, Jinhua Wang, Yuanyuan Li, Ping Chen, Stephen Arnovitz, Shenglai Li, Yungui Wang, Hengyou Weng, PhD, Mary Elizabeth Neilly, Zejuan Li, MD PhD, Jianjun Chen, PhD

Blood (2014) 124 (21): 1011.

https://doi.org/10.1182/blood.V124.21.1011.1011

Published: 2014

Journal Articles

High Musashi-2 Expression Is an Unfavorable Prognostic Factor in Adult B-Cell Acute Lymphoblastic Leukemia.

Qitian Mu, Yungui Wang, Bing Chen, Wenbin Qian, MD, Haitao Meng, MD, Hongyan Tong, MD, Feifei Chen, Qiuling Ma, Wangmao Ni, Sai-Juan Chen, Jie Jin, MD

Blood (2012) 120 (21): 2508.

https://doi.org/10.1182/blood.V120.21.2508.2508

Published: 2012

Journal Articles

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Qitian Mu, Qiuling Ma, Yungui Wang, Xiangmin Tong, Zhimei Chen, Jiyu Lou, Yizhi Cheng, Ying Lu, Wangmao Ni, Feifei Chen, Jie Jin, MD

Blood (2011) 118 (21): 4888.

https://doi.org/10.1182/blood.V118.21.4888.4888

Published: 2011

Journal Articles

MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia.

Shuangli Mi, PhD, Jun Lu, Ph.D., Miao Sun, M.S., Zejuan Li, Ph.D., Hao Zhang, M.S., Mary Beth Neilly, M.S., Yungui Wang, Ph.D., Zhijian Qian, Ph.D., Jie Jin, M.D., Yanming Zhang, M.D., Stefan K. Bohlander, M.D., Michelle M. Le, B.A., Richard Larson, M.D., Todd R. Golub, M.D., Janet D. Rowley, M.D., Jianjun Chen, Ph.D.

Blood (2007) 110 (11): 231.

https://doi.org/10.1182/blood.V110.11.231.231

Published: 2007

NARROW

High Expression of BCAT1 Affects DNA Damage Response By Inhibiting α-KG-Dependent Histone Demethylase

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia

High Expression of BCAT1 promotes Acute Myeloid Leukemia Progression and Sensitize to PARP Inhibitor

Multidimensional Study on the Prognostic Factors of Acute Myeloid Leukemia Patients with FLT3-ITD mutations Based on the Next-Generation Sequencing Platform

Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia

Fto Plays an Oncogenic Role in Acute Myeloid Leukemia As a N 6 -Methyladenosine RNA Demethylase

TET1 Regulates DNA Replication through Targeting of Minichromosome Maintenance Genes

Alox5 Functions As Both Tumor Suppressor and Drug Sensitizer in AML

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Overexpression and Knockout of Mir-126 Both Promote Leukemogenesis through Targeting Distinct Gene Signaling

Uncover TET1 Targets in MLL -Rearranged Leukemia

Targeted Treatment of FLT3 -Overexpressing Acute Myeloid Leukemia with MiR-150 Nanoparticles Guided By Conjugated FLT3 Ligand Peptides

Mircrorna-550 Functions As a Critical Tumor Suppressor in Acute Myeloid Leukemia

Overexpression and knockout of miR-126 both promote leukemogenesis

Identification of TET1⊣miR-22⊣CREB-MYC Signaling Reveals Potent Tumor-Suppressor Role of Mir-22 in Acute Myeloid Leukemia

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL -Rearranged Leukemia

High Musashi-2 Expression Is an Unfavorable Prognostic Factor in Adult B-Cell Acute Lymphoblastic Leukemia.

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only